Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE

Load latest

Bharat Immunological & Biologicals Corporation Ltd.

27 Jul 2017

23.49

1.34%

Result

Un Audited Quarterly Financial Results For The Quarter Ended 30/06/2017

BSE India

To The Listing Agreement Bombay Stock Exchange Phiroze Jeejeebhoy Towers, 25, Dalal Street, Mumbai 400 001. Ref: Submission of Limited Review Report of the Quarterly Unaudited financial Results for the quarter ended June 2017 under Regulation 33(3)(C ) of LODR Sir, In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with...

pdf

Bharat Immunological & Biologicals Corporation Ltd.

25 Jul 2017

23.49

1.34%

Result

Updates

BSE India

No. BIB/CS/SE/UAFR/Q1/2017-18 Dated 25.07.2017 To, The Listing Department Bombay Stock Exchange Phiroze Jeejeebhoy Towers 25, Dalal Street, Mumbai 400 001. Sub:- Submission of Quarterly Unaudited Financial Results for the quarter ended June 2017 Sir, In compliance of SEBI' s LODR, the XBRL filing of unaudited quarterly financial results will be submitted online at BSE Listing...

pdf

Bharat Immunological & Biologicals Corporation Ltd.

10 Jul 2017

23.49

1.34%

Board Meeting

Intimation Of Date Of Board Meeting(25.07.2017) Under Regulation 29 Of SEBI'S LODR.

BSE India

Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 25th July 2017 at Delhi, to approve and take on record the Un-audited Quarterly Financial Results of the Company for the quarter ended 30th June 2017.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

10 Jul 2017

23.49

1.34%

Company Update

Change in RTA

BSE India

Sub: Intimation for Change in Registrar and Transfer Agent of the Company. Sir, As per the Tendering system within the meaning of General Financial Rules 2017 of the Ministry of Finance, Company has changed its Registrar and Transfer Agent. Kind request to change in our Registrar and Transfer agent from Beetal Financial & Computer services (P) Ltd. to MAS Services Limited w.e.f. 01.07.2017 is submitted for information and to take on record please....

pdf

Bharat Immunological & Biologicals Corporation Ltd.

10 Jul 2017

23.49

1.34%

Company Update

Shareholding for the Period Ended June 30, 2017

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

24 May 2017

23.49

1.34%

Corp. Note

Sub:- Certificate From Practicing Company Secretary Under Regulation 40 Of SEBI (LODR) Regulations 2015 For The …

BSE India

Sir, In pursuance of Regulation 40 of the LODR with Stock Exchange, please find attached the Certificate from Practicing Company Secretary for the half year ended 31st March 2017. It is requested to take the above on record.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

10 May 2017

23.49

1.34%

Result

LIMITED REVIEW REPORT ON UN-AUDITED QUARTERLY FINANCIAL RESULTS FOR THE QUARTER ENDED MARCH 30, 2017

BSE India

Ref:Submission of Limited Review Report of the Quarterly Unaudited financial Results for the quarter ended March 2017 under Regulation 33(3)(C ) of LODR Sir, In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 31st March 2017. It is requested to kindly take the above on record please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

09 May 2017

23.49

1.34%

Annual Report

Annual report for Bharat Immunological & Biologicals Corporation Ltd. for FY-2017

pdf

Bharat Immunological & Biologicals Corporation Ltd.

05 May 2017

23.49

1.34%

Company Update

Updates

BSE India

FINANCIAL QUARTERLY RESULTS FOR THE QUARTER ENDED MARCH 2017

Bharat Immunological & Biologicals Corporation Ltd.

05 Apr 2017

23.49

1.34%

Company Update

Shareholding for the Period Ended March 31, 2017

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here

Is Bharat Immunological & Biologicals Corporation Ltd. worth buying?

135 Votes:

Buy 69.63%

Sell 14.81%

Hold 15.56%